[Natural history and management of retroperitoneal sarcoma: Review of the literature by the Oncology committee of the French association of urology].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 21693353)

Published in Prog Urol on April 14, 2011

Authors

C Avancès1, P Camparo, F Quenet, X Durand, S Culine, P Sèbe, M Soulié, J Rigaud, Comité de Cancérologie de l'Association Française d'Urologie - groupe Organes Génitaux Externes (CCAFU-OGE)

Author Affiliations

1: Service d'urologie, clinique kenVal, 30000 Nîmes, France. christophe.avances@free.fr

Articles by these authors

Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol (2004) 4.15

European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol (2004) 2.65

Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients. Eur J Surg Oncol (2013) 2.33

Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood (2001) 1.98

Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer. Eur J Cancer (2004) 1.93

Nitrate reductase from bacteroides of Rhizobium japonicum: enzyme characteristics and possible interaction with nitrogen fixation. Biochim Biophys Acta (1975) 1.90

Effect of nitrite upon leghemoglobin and interaction with nitrogen fixation. Biochim Biophys Acta (1977) 1.79

The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients. Eur J Cancer (2000) 1.74

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy. J Clin Oncol (1997) 1.67

Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network. Ann Oncol (2010) 1.65

Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy. Ann Oncol (2013) 1.58

Prognostic value of MET, RON and histoprognostic factors for urothelial carcinoma in the upper urinary tract. J Urol (2008) 1.56

Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol (2010) 1.49

[Prospective evaluation of intrasphincteric injections of autologous muscular cells in patients with stress urinary incontinence following radical prostatectomy]. Prog Urol (2011) 1.41

[Recommendations for the treatment of prostate cancer in the elderly man: A study by the oncology committee of the French association of urology]. Prog Urol (2009) 1.40

High failure rate of carboplatin-etoposide combination in good risk non-seminomatous germ cell tumours. Eur J Cancer (1993) 1.39

Haemodynamic changes during retroperitoneoscopic adrenalectomy for phaeochromocytoma. Br J Anaesth (2001) 1.38

Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials. Ann Oncol (1995) 1.32

Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations. Cancer Res (2000) 1.30

Nitrogen Fixation (C(2)H(2) Reduction) by Broad Bean (Vicia faba L.) Nodules and Bacteroids under Water-Restricted Conditions. Plant Physiol (1990) 1.25

Five-year change in statistical designs of phase II trials published in leading cancer journals. Eur J Cancer (2004) 1.24

Desmoplastic small round cell tumors: results of a four-drug chemotherapy regimen in five adult patients. Cancer (1996) 1.23

The human homologue of the putative proto-oncogene Spi-1: characterization and expression in tumors. Oncogene (1990) 1.21

Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group. J Clin Oncol (2001) 1.20

Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: a phase II study of the Genitourinary Group of the French Federation of Cancer Centers. J Urol (2002) 1.18

Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial. Ann Oncol (2011) 1.17

Phosphorylated intermediate of a transport ATPase and activity of protein kinase in membranes from corn roots. Eur J Biochem (1983) 1.15

[Auxin content, auxin catabolism and growth of Rhizobium]. Arch Mikrobiol (1969) 1.14

Electrostatic analysis of effects of ions on the inhibition of corn root plasma membrane Mg2+-ATPase by the bivalent orthovanadate. Biochim Biophys Acta (1989) 1.10

Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure. CPT-11 F205, F220, F221 and V222 study groups. Br J Cancer (2000) 1.09

Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapse. Eur J Cancer (2001) 1.06

Reversible posterior leukoencephalopathy syndrome after carboplatin therapy. Ann Oncol (2006) 1.05

Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002). Br J Cancer (2003) 1.05

Primary mediastinal nonseminomatous germ cell tumors: results of modern therapy including cisplatin-based chemotherapy. J Clin Oncol (1998) 1.04

[Indole-3-lactic acid and its metabolism by Rhizobium]. Arch Mikrobiol (1970) 1.04

[Malignant-like angiomyolipoma of the liver: report of one case and review of the literature]. Ann Chir (2005) 1.04

Lipid peroxidation in peribacteroid membranes from French-bean nodules. Plant Physiol (1991) 1.03

Adult granulosa-cell tumor of the ovary: a retrospective study of 45 cases. Int J Gynecol Cancer (1997) 1.03

Potassium stimulation of corn root plasmalemma ATPase : I. Hydrolytic activity of native vesicles and purified enzyme. Plant Physiol (1990) 1.02

[Leiomyosarcoma of the middle segment of the inferior vena cava: tactical problems raised by renal and caval revascularisation]. J Mal Vasc (2006) 1.01

Increased expression of class III beta-tubulin in castration-resistant human prostate cancer. Br J Cancer (2009) 1.00

Fibrous pseudotumor of the epididymis: imaging and pathologic correlation. Eur Radiol (2000) 0.99

Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients. Cancer Res (1994) 0.99

Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy? Br J Cancer (2007) 0.98

Peroxidase content of soybean root nodules. Biochim Biophys Acta (1980) 0.98

[Etiologic spectrum of mesenteric panniculitis: report of 7 cases]. Rev Med Interne (2007) 0.97

Preparation of Corn Root Plasmalemma with Low Mg-ATPase Latency and High Electrogenic H Pumping Activity after Phase Partitioning. Plant Physiol (1988) 0.96

Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients. Eur J Surg Oncol (2008) 0.96

Is robotic-assisted ventral mesh rectopexy superior to laparoscopic ventral mesh rectopexy in the management of obstructed defaecation? Colorectal Dis (2013) 0.96

Second non-germ cell malignancies in patients treated for stage I-II testicular seminoma. Radiother Oncol (1999) 0.95

Nitrite and nitric oxide as inhibitors of nitrogenase from soybean bacteroids. Appl Environ Microbiol (1982) 0.95

Phase II study of oxaliplatin and fluorouracil in taxane- and anthracycline-pretreated breast cancer patients. J Clin Oncol (2002) 0.95

Phase II multicentre randomised study of docetaxel plus epirubicin vs 5-fluorouracil plus epirubicin and cyclophosphamide in metastatic breast cancer. Br J Cancer (2004) 0.95

Radical cystectomy in patients older than 75 years: assessment of morbidity and mortality. Eur Urol (2001) 0.95

Prompt resolution of acute disseminated intravascular coagulation with docetaxel and cisplatin in hormone refractory prostate cancer. J Urol (2002) 0.94

Treatment outcome of patients with brain metastases from malignant germ cell tumors. Cancer (1999) 0.94

The growing teratoma syndrome: a woman with nonseminomatous germ cell tumor of the ovary. Gynecol Oncol (1993) 0.93

Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial. Ann Oncol (2005) 0.92

Aurora-A/STK-15 is a predictive factor for recurrent behaviour in non-invasive bladder carcinoma: a study of 128 cases of non-invasive neoplasms. Virchows Arch (2007) 0.92

A new class of wine pigments generated by reaction between pyruvic acid and grape anthocyanins. Phytochemistry (1998) 0.92

Late ureteral stenosis following renal transplantation: risk factors and impact on patient and graft survival. Am J Transplant (2006) 0.92

Hyperthermic intra-peritoneal chemotherapy using oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study. Eur J Surg Oncol (2010) 0.91

Long-term results of venous revascularization for Paget-Schroetter syndrome in athletes. Ann Vasc Surg (2001) 0.91

Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor. Ann Oncol (2008) 0.90

Total laparoscopic radical hysterectomy for locally advanced cervical carcinoma (stages IIB, IIA and bulky stages IB) after concurrent chemoradiation therapy: surgical morbidity and oncological results. Gynecol Oncol (2009) 0.90

Primary peritoneal serous carcinoma treated by cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. A multi-institutional study of 36 patients. Eur J Surg Oncol (2013) 0.90

[Synthesis of indolyl-3-lactic acid and tryptophol by Rhizobium cultivated in the presence of tryptophan]. C R Acad Sci Hebd Seances Acad Sci D (1966) 0.90

Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients: the Institut Gustave Roussy experience. Cancer (1996) 0.90

Variation in reporting of cancer extent and benign histology in prostate biopsies among European pathologists. Virchows Arch (2014) 0.87

[Axillary block of the brachial plexus and flunitrazepam premedication in surgery of the upper limb (study of 1,500 cases)]. Cah Anesthesiol (1984) 0.87

An in vivo study of a nonstructural polypeptide synthesize upon TMV infection and its identification with a polypeptide synthesized in vitro from TMV RNA. Virology (1978) 0.87

[Malignant hereditary paraganglioma: problems raised by non-functional forms management]. Ann Chir (2006) 0.87

[CCAFU Recommendations 2013: Renal cancer]. Prog Urol (2013) 0.87

Minimally invasive ventral mesh rectopexy for complex rectocoele: impact on anorectal and sexual function. Colorectal Dis (2011) 0.87

Initial management of primary mediastinal seminoma: radiotherapy or cisplatin-based chemotherapy? Eur J Cancer (1998) 0.87

[Characteristics of prostate cancer in men less than 50-year-old]. Prog Urol (2009) 0.86

Patient preference for either the EORTC QLQ-C30 or the FACIT Quality Of Life (QOL) measures: a study performed in patients suffering from carcinoma of an unknown primary site (CUP). Eur J Cancer (2004) 0.86

[WHO classification 2004: tumors of the kidneys]. J Radiol (2006) 0.86

Oxaliplatin in non-seminomatous germ-cell tumors. Ann Oncol (2004) 0.86

Medical and non-medical determinants of prostate cancer management: a population-based study. Eur J Cancer (2003) 0.86

Localization of a protease in protoplast preparations in infected cells of French bean nodules. Plant Physiol (1991) 0.85

[The French clinical trials ongoing (GETUG and AFU) on urothelial carcinomas, kidney and prostate cancers]. Prog Urol (2010) 0.85

[Prospective study of the results of ureterointestinal anastomosis in 100 patients after the Hautmann ileal neobladder with double chimney]. Prog Urol (2011) 0.85

Bayesian estimate of vinorelbine pharmacokinetic parameters in elderly patients with advanced metastatic cancer. Clin Cancer Res (2000) 0.85

[Extradural spinal meningioma: case report]. Neurochirurgie (2008) 0.85

Kinetic studies of the reaction of ferric soybean leghemoglobins with hydrogen peroxide, cyanide and nicotinic acid. Eur J Biochem (1980) 0.85

[Recommendations Onco-Urology 2010: Prostate cancer]. Prog Urol (2010) 0.85

[Malignant tumors of the adrenal: contribution to the repository CCAFU INCa]. Prog Urol (2010) 0.84

[Symptomatic approach to chronic pudendal pain]. Prog Urol (2010) 0.84

[Drug treatments in the therapeutic management of chronic pelvic and perineal pain]. Prog Urol (2010) 0.84

[CCAFU Recommendations 2013: Prostate cancer]. Prog Urol (2013) 0.83

The value of endoscopic rectal ultrasound in predicting the lateral clearance and outcome in patients with lower-third rectal adenocarcinoma. Endoscopy (2007) 0.83

[Renal carcinoma associated with MiTF/TFE translocation: report of six cases in young adults]. Prog Urol (2008) 0.83

A phase I and pharmacokinetic study of melphalan using a 24-hour continuous infusion in patients with advanced malignancies. Clin Cancer Res (2000) 0.83

Spontaneous insertion of plant plasma membrane (H+)ATPase into a preformed bilayer. J Membr Biol (1991) 0.83

[Verrucous epidermoid carcinoma of the bladder unrelated to schistosomiasis]. Prog Urol (2001) 0.82